Table 3.
Partial Spearman’s correlation coefficients adjusted for age, sex and body mass index (BMI).
| miR-30a-5p (2–ΔCt) | miR-1299 (2–ΔCt) | miR-182-5p (2–ΔCt) | miR-30e-3p (2–ΔCt) | miR-126-3p (2–ΔCt) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Adjusted for age, BMI and sex | r | value of p | r | value of p | r | value of p | r | value of p | r | value of p |
| miR-30a-5p (2–ΔCt) | 1.000 | – | 0.497 | 0.001 | 0.739 | <0.001 | 0.668 | <0.001 | 0.587 | <0.001 |
| miR-1299 (2–ΔCt) | 0.497 | 0.001 | 1.000 | – | 0.582 | <0.001 | 0.452 | 0.002 | 0.275 | 0.075 |
| miR-182-5p (2–ΔCt) | 0.739 | <0.001 | 0.582 | <0.001 | 1.000 | – | 0.488 | 0.001 | 0.620 | <0.001 |
| miR-30e-3p (2–ΔCt) | 0.668 | <0.001 | 0.452 | 0.002 | 0.488 | 0.001 | 1.000 | – | 0.562 | <0.001 |
| miR-126-3p (2–ΔCt) | 0.587 | <0.001 | 0.275 | 0.075 | 0.620 | <0.001 | 0.562 | <0.001 | 1.000 | – |
| Waist circumference | −0.078 | 0.618 | −0.002 | 0.988 | −0.134 | 0.392 | −0.067 | 0.670 | −0.200 | 0.198 |
| Hip circumference (cm) | −0.076 | 0.628 | 0.000 | 0.998 | −0.130 | 0.406 | −0.065 | 0.681 | −0.197 | 0.205 |
| Systolic blood pressure (mmHg) | −0.173 | 0.266 | −0.164 | 0.293 | −0.227 | 0.143 | −0.151 | 0.335 | −0.164 | 0.292 |
| Diastolic blood pressure (mmHg) | −0.155 | 0.320 | −0.149 | 0.340 | −0.206 | 0.186 | −0.135 | 0.389 | −0.150 | 0.338 |
| Glucose (Fasting) (mmol/L) | −0.308 | 0.045 | −0.207 | 0.183 | −0.227 | 0.144 | −0.315 | 0.040 | −0.247 | 0.110 |
| HbA1c (%) | −0.260 | 0.093 | −0.247 | 0.110 | −0.247 | 0.111 | −0.318 | 0.037 | −0.232 | 0.134 |
| Insulin Fasting (mIU/L) | −0.171 | 0.273 | −0.181 | 0.245 | −0.200 | 0.198 | −0.221 | 0.154 | −0.211 | 0.175 |
| Triglycerides-S (mmol/L) | −0.319 | 0.037 | −0.281 | 0.068 | −0.297 | 0.053 | −0.371 | 0.014 | −0.280 | 0.069 |
| Cholesterol HDL-S (mmol/L) | −0.381 | 0.012 | −0.306 | 0.046 | −0.326 | 0.033 | −0.388 | 0.010 | −0.312 | 0.041 |
| Cholesterol LDL-S (mmol/L) | −0.297 | 0.053 | −0.280 | 0.069 | −0.281 | 0.068 | −0.300 | 0.051 | −0.222 | 0.153 |
| Cholesterol-S (mmol/L) | −0.385 | 0.011 | −0.293 | 0.056 | −0.320 | 0.036 | −0.434 | 0.004 | −0.326 | 0.033 |
| usCRP (mg/L) | −0.388 | 0.010 | −0.306 | 0.046 | −0.323 | 0.035 | −0.435 | 0.004 | −0.325 | 0.033 |
| Gamma GT-S (IU/L) | −0.385 | 0.011 | −0.294 | 0.056 | −0.320 | 0.037 | −0.434 | 0.004 | −0.325 | 0.033 |
| S-Creatinine (umol/L) | −0.390 | 0.007 | −0.303 | 0.039 | −0.328 | 0.025 | −0.427 | 0.003 | −0.328 | 0.024 |
| MDRD eGFR (ml/min) | −0.383 | 0.011 | −0.306 | 0.046 | −0.318 | 0.038 | −0.425 | 0.004 | −0.319 | 0.037 |
| CKD-EPI eGFR (ml/min) | −0.382 | 0.011 | −0.305 | 0.047 | −0.316 | 0.039 | −0.424 | 0.005 | −0.318 | 0.038 |
Cholesterol HDL-S, serum high-density lipoprotein cholesterol; cholesterol LDL-S, serum low-density lipoprotein cholesterol; cholesterol-S, serum total cholesterol; usCRP, ultrasensitive C-reactive protein; gamma GT-S – serum gamma-glutamyl transferase; S-creatinine – serum creatinine; MDRD eGFR, Modification of Diet in Renal Disease estimated glomerular filtration rate; and CKD-EPI eGFR, Chronic Kidney Disease Epidemiology Collaboration estimated glomerular filtration rate.